EDIT:NASDAQ
Editas Medicine Inc
$2.68
arrow_upward
+0.94%(+0.025) 1D
Sep 11, 2:06:20 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.68
High
$2.72
Low
$2.62
Mkt. cap
410.83M
Avg. vol.
2.34M
Volume
1.34M
52-wk high
$4.54
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.68
High
$2.72
Low
$2.62
Mkt. cap
410.83M
Avg. vol.
2.34M
Volume
1.34M
52-wk high
$4.54
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
MarketBeat
·
8 hours ago
Opaleye Management Inc. Buys 1,934,933 Shares of Editas Medicine, Inc. $EDIT
Investing.com
·
21 hours ago
Editas Medicine at Cantor conference: in vivo CRISPR push advances
Stock Titan
·
1 day ago
Editas Medicine (NASDAQ: EDIT) awards options vesting through 2030 to its CMO
Stock Titan
·
2 days ago
New medical chief can earn the right to buy 950,000 Editas shares
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc